Answers are grounded in this paper and cite their sources.
Widening the scale from 7 (AI) to 12 points (TRACE) increased the clinical sensitivity to changes of the aesthetic scale, even if TRACE has only a fair repeatability. TRACE is a no-cost tool for routine clinical practice in AIS patients. Due to the absence of other comparable validated tools, once the inherent measurement error is known and understood, its routine clinical use by physicians is advised.
No takes yet. Share an insight, caveat, or question.
Zaina et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: